Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Khattar Jack A.
President, CEO at SUPERNUS PHARMACEUTICALS. Filing since 4 May 2012.
CIK 0001539937
Company
Date
Role
Action
Shares
Amount
Of holding
SUPN
SUPERNUS PHARMACEUTICALS, INC.
13 Mar 2026
President, CEO
Sold on a plan
35,000
$1.76M
3.5%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
9 Oct 2025
President, CEO
Sold on a plan
59,900
$3.03M
4.7%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
2 Oct 2025
President, CEO
Sold on a plan
1,904
$91.51K
0.2%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
1 Oct 2025
President, CEO
Sold on a plan
40,173
$1.93M
3.3%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
30 Sep 2025
President, CEO
Sold on a plan
8,588
$414.37K
0.7%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
29 Sep 2025
President, CEO
Sold on a plan
10,235
$491.48K
0.9%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
23 Sep 2025
President, CEO
Sold on a plan
29,513
$1.39M
2.5%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
22 Sep 2025
President, CEO
Sold on a plan
16,587
$779.92K
1.5%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
8 Sep 2025
President, CEO
Sold on a plan
6,322
$292.65K
0.6%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
5 Sep 2025
President, CEO
Sold on a plan
55,578
$2.56M
4.8%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
28 Aug 2025
President, CEO
Sold on a plan
24,150
$1.09M
2.2%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
27 Aug 2025
President, CEO
Sold on a plan
10,650
$479.78K
1.0%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
25 Aug 2025
President, CEO
Sold on a plan
1,000
$45.00K
0.1%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
22 Aug 2025
President, CEO
Sold on a plan
1,500
$67.50K
0.1%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
6 Aug 2025
President, CEO
Sold on a plan
140,000
$5.88M
12.0%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
8 Nov 2024
President, CEO
Sold at will
125,000
$4.54M
11.9%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
7 Nov 2024
President, CEO
Sold at will
125,000
$4.59M
11.9%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
3 Feb 2023
President, CEO
Bought
200
$8.40K
0.0%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
2 Feb 2023
President, CEO
Sold, plan not stated
13,532
$569.09K
1.7%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
1 Feb 2023
President, CEO
Sold, plan not stated
300
$12.60K
0.0%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
31 Jan 2023
President, CEO
Sold, plan not stated
976
$41.00K
0.1%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
18 Jan 2023
President, CEO
Sold, plan not stated
4,936
$199.39K
0.6%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
17 Jan 2023
President, CEO
Sold, plan not stated
25,446
$1.02M
3.1%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
21 Dec 2022
President, CEO
Sold, plan not stated
11,354
$433.07K
1.4%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
20 Dec 2022
President, CEO
Sold, plan not stated
4,006
$152.32K
0.5%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
25 Nov 2022
President, CEO
Sold, plan not stated
11,135
$391.68K
1.4%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
23 Nov 2022
President, CEO
Sold, plan not stated
2,259
$79.19K
0.3%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
22 Nov 2022
President, CEO
Sold, plan not stated
600
$21.00K
0.1%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
21 Nov 2022
President, CEO
Sold, plan not stated
531
$18.59K
0.1%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
15 Nov 2022
President, CEO
Sold, plan not stated
1,115
$39.03K
0.1%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
16 Aug 2022
President, CEO
Sold, plan not stated
14,690
$499.65K
1.9%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
15 Aug 2022
President, CEO
Sold, plan not stated
17,302
$588.75K
2.2%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
10 Aug 2022
President, CEO
Sold, plan not stated
28,437
$887.80K
3.7%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
9 Aug 2022
President, CEO
Sold, plan not stated
39,431
$1.23M
5.2%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
8 Aug 2022
President, CEO
Sold, plan not stated
117,907
$3.71M
14.4%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
23 Aug 2019
President, CEO
Bought
7,200
$189.98K
1.6%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
15 Mar 2013
President, CEO
Bought
10,000
$61.46K
2.5%
SUPN
SUPERNUS PHARMACEUTICALS, INC.
4 May 2012
President, CEO
Bought
5,000
$25.00K
1.3%
38 decisions on file.
